Funding Opportunities

NIH Funding Opportunities

Notice of Change in Types of Applications Allowed for PAR-13-319 "Alcohol Research Resource Awards (R24)"
Notice NOT-AA-15-010 from the NIH Guide for Grants and Contracts
Fri, 27 Mar 2015 02:36:15 EST

Notice of Termination of RFA-AI-14-045 "Hepatitis C Virus Cooperative Research Centers: Immunity to HCV Infection (U19)"
Notice NOT-AI-15-026 from the NIH Guide for Grants and Contracts
Thu, 26 Mar 2015 03:37:03 EST

Notice of an Extension of Expiration Date for PA-12-037 Research to Advance Vaccine Safety (R01)
Notice NOT-AI-15-027 from the NIH Guide for Grants and Contracts
Thu, 26 Mar 2015 10:47:24 EST

Notice of an Extension of Expiration Date for PA-12-038 Research to Advance Vaccine Safety (R21)
Notice NOT-AI-15-028 from the NIH Guide for Grants and Contracts
Thu, 26 Mar 2015 03:34:19 EST

Notice of an Update to the Eligibility Information in PAR-15-131 "Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11)"
Notice NOT-AI-15-030 from the NIH Guide for Grants and Contracts
Tue, 24 Mar 2015 02:35:42 EST

Notice of Information: Announcement of Q and As for PAR-15-131 "Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11)"
Notice NOT-AI-15-031 from the NIH Guide for Grants and Contracts
Tue, 24 Mar 2015 02:38:25 EST

Notice of Pre-Application Webinar for RFA-AR-15-014 "Validation of Pediatric Patient Reported Outcomes in Chronic Diseases (PEPR) Consortium (U19)"
Notice NOT-AR-15-016 from the NIH Guide for Grants and Contracts
Thu, 26 Mar 2015 03:03:09 EST

Notice of Extension of the Response Date for NOT-AR-15 -010 "Request for Information (RFI): Core Centers for Clinical Research (CCCR)"
Notice NOT-AR-15-017 from the NIH Guide for Grants and Contracts
Tue, 24 Mar 2015 01:35:53 EST

Request for Proposals (RFP) Notice: Population Assessment of Tobacco and Health (PATH) Study
Notice NOT-DA-15-060 from the NIH Guide for Grants and Contracts
Tue, 24 Mar 2015 02:18:06 EST

Notice of Change in Age Range to Include Young Adults up to 25 years of age in PA-15-035 "Research Aimed at Novel Behavioral Targets to Improve Adolescent Substance Abuse Treatment and Prevention Interventions (R34)"
Notice NOT-DA-15-061 from the NIH Guide for Grants and Contracts
Tue, 24 Mar 2015 02:21:33 EST

Notice of Change in Age Range to Include Young Adults up to 25 years of age in PA-15-036 "Research Aimed at Novel Behavioral Targets to Improve Adolescent Substance Abuse Treatment and Prevention Interventions (R01)"
Notice NOT-DA-15-062 from the NIH Guide for Grants and Contracts
Tue, 24 Mar 2015 02:24:10 EST

Notice of Clarification of Letter of Intent (LOI) Due Date(s) for NIDA PA-15-099 "Reductions in Illicit Drug Use and Functional Outcomes (R21/R33)"
Notice NOT-DA-15-063 from the NIH Guide for Grants and Contracts
Fri, 27 Mar 2015 01:29:38 EST

Notice of Clarification for RFA-HD-15-034 Developing Paradigm-Shifting Innovations for in vivo Human Placental Assessment in Response to Environmental Influences (U01)
Notice NOT-HD-15-014 from the NIH Guide for Grants and Contracts
Fri, 27 Mar 2015 01:44:44 EST

Request for Information (RFI): NHLBI Strategic Visioning - Developing the Research Priorities for the Next Decade
Notice NOT-HL-15-252 from the NIH Guide for Grants and Contracts
Tue, 24 Mar 2015 10:10:04 EST

Notice of Change to Award Information Regarding Allowable Requested Direct Costs in PAR-13-316 "NHLBI Program Project Applications (P01)"
Notice NOT-HL-15-256 from the NIH Guide for Grants and Contracts
Thu, 26 Mar 2015 03:41:52 EST

Notice of National Heart, Lung, and Blood Institute (NHLBI) Participation in PAR-15-085 "Predictive Multiscale Models for Biomedical, Biological, Behavioral, Environmental and Clinical Research (U01)"
Notice NOT-HL-15-257 from the NIH Guide for Grants and Contracts
Fri, 27 Mar 2015 02:43:14 EST

Notice of Pre-Application Technical Assistance Conference Call for RFA-HS-15-002 "AHRQ Health Services Research Projects: Making Health Care Safer in Ambulatory Care Settings and Long Term Care Facilities (R01)"
Notice NOT-HS-15-008 from the NIH Guide for Grants and Contracts
Wed, 25 Mar 2015 11:45:44 EST

Notice of Correction of the First Advisory Council Review Date for PAR-15-121 "BRAIN Initiative: Optimization of Novel Tools and Technologies for Neuroscience Research (R44)"
Notice NOT-NS-15-017 from the NIH Guide for Grants and Contracts
Thu, 26 Mar 2015 10:40:22 EST

Notice of Correction to the Budget Instructions for PAR-15-070 "Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Therapeutic Agent Identification and Characterization to Support Therapeutic Discovery (R21/R33)"
Notice NOT-NS-15-018 from the NIH Guide for Grants and Contracts
Tue, 24 Mar 2015 02:30:54 EST

Notice of Correction to the Budget Instructions for PAR-15-071 " Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Pharmacodynamics and In vivo Efficacy Studies for Small Molecules and Biologics/Biotechnology Products (R21/R33)"
Notice NOT-NS-15-019 from the NIH Guide for Grants and Contracts
Tue, 24 Mar 2015 02:27:46 EST

Reminder: NIH and AHRQ Biosketch Requirements for Due Dates On or After May 25, 2015
Notice NOT-OD-15-085 from the NIH Guide for Grants and Contracts
Tue, 24 Mar 2015 10:07:53 EST

Notice for Use of Cloud Computing Services for Storage and Analysis of Controlled-Access Data Subject to the NIH Genomic Data Sharing (GDS) Policy
Notice NOT-OD-15-086 from the NIH Guide for Grants and Contracts
Fri, 27 Mar 2015 01:54:04 EST

Mechanisms of Immune Protection from TB among HIV-infected Individuals (R01)
Funding Opportunity RFA-AI-14-072 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support studies characterizing the genetic, epigenetic, and/or immunological correlates of protection against tuberculosis infection in highly-exposed but resistant individuals, and the interaction of these correlates with HIV infection. Studies may include identification of underlying genetic or epigenetic factors, as well as characteristics of the innate immune system and related regulatory genes and signaling pathways that play a role in protection from latent tuberculosis infection (LTBI).Multidisciplinary collaboration is encouraged, incorporating clinical studies coupled with functional experiments using samples and data from well-defined cohorts.
Thu, 26 Mar 2015 02:57:53 EST

Research Answers to NCI's Provocative Questions (R01)
Funding Opportunity RFA-CA-15-008 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research projects designed to solve specific problems and paradoxes in cancer research identified by the National Cancer Institute (NCI) Provocative Questions initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific problems in key areas of cancer research that are deemed important but have not received sufficient attention.
Fri, 27 Mar 2015 01:21:39 EST

Research Answers to NCI's Provocative Questions (R21)
Funding Opportunity RFA-CA-15-009 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research projects designed to solve specific problems and paradoxes in cancer research identified by the National Cancer Institute (NCI) Provocative Questions initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific problems in key areas of cancer research that are deemed important but have not received sufficient attention.
Fri, 27 Mar 2015 01:21:23 EST

Limited Competition: Revisions to Add Phase 2 Clinical Trials Program to Experimental Therapeutics Clinical Trials Network (ETCTN)(UM1)
Funding Opportunity RFA-CA-15-501 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to enhance the NCI-supported early development of experimental cancer therapeutics by merging the Phase 2 clinical trials program with the Experimental Therapeutics Clinical Trials Network (ETCTN, funded through RFA-CA-13-006) that is currently focused on Phase 1 clinical trials. The FOA invites revision applications from ETCTN UM1 awardees to expand the scope of activities by adding capabilities to conduct Phase 2 clinical trials. The goal is to integrate Phase 2 infrastructure and expertise to create a unified network for an efficient and comprehensive conduct of early clinical trials. This integration of the Phase 2 capabilities into the new ETCTN structure will allow for more seamless advancement of experimental agents through early stages of development. Ultimately, the expected increased efficiency of clinical trial management is expected to accelerate the delivery of new cancer therapies to the public.
Mon, 23 Mar 2015 01:44:58 EST

Limited Competition for the Continuation of Look AHEAD (Action for Health in Diabetes) Clinical Centers (Collaborative U01)
Funding Opportunity RFA-DK-15-501 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is a limited competition FOA inviting cooperative agreement (U01) applications from the Clinical Centers for the Look AHEAD (Action for Health in Diabetes) Consortium. The purpose of this limited competition will be to allow an additional 5 year follow-up period of all currently enrolled participants. RFA-DK-15-502 will support continuation of the Look AHEAD Biostatistics Research Center.
Thu, 26 Mar 2015 04:07:19 EST

Limited Competition for the Continuation of Look AHEAD (Action for Health in Diabetes) Biostatistics Research Center (Collaborative U01)
Funding Opportunity RFA-DK-15-502 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is a limited competition FOA inviting cooperative agreement (U01) applications from the Biostatistics Research Center for the Look AHEAD (Action for Health in Diabetes) Consortium. The purpose of this limited competition will be to allow an additional 5 year follow-up period of all currently enrolled participants. RFA-DK-15-501 will support continuation of the Look AHEAD Clinical Centers.
Thu, 26 Mar 2015 04:07:09 EST

Pediatric Research using Integrated Sensor Monitoring Systems (PRISMS): Sensor Development Projects for Asthma (U01)
Funding Opportunity RFA-EB-15-002 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is toencourage U01 Cooperative Agreement applications for the development of wearable and non-wearable sensors that can monitor pediatric environmental exposures, physiological signals, activity, and/or behavior in a natural environment to gain new insights into environmental determinants of asthma. These sensors (newly developed, existing, or redesigned) will need to be able to plug and play, physically or wirelessly, with informatics platforms that will be developed in FOA RFA-EB-15-003.The platforms will be designed for data acquisition (from the sensors), integration, processing, visualization, and secure uploading of individual platform results to a data and software coordination and integration center that will be developed in FOA RFA-EB-15-004. The three FOAs together (RFA-EB-15-002, RFA-EB-15-003, RFA-EB-15-004) will make up the Pediatric Research using Integrated Senor Monitoring Systems (PRISMS) Program. The central mission of the PRISMS Program is to develop sensor-based integrated health monitoring systems to serve as research tools to measure pediatric environmental, physiological, and behavioral factors in epidemiological studies of asthma, and eventually other chronic diseases, in the pediatric population. The three arms to the PRISMS Program will work very closely together to ensure functionality of the overall systems.
Wed, 25 Mar 2015 11:14:40 EST

Pediatric Research Using Integrated Sensor Monitoring Systems (PRISMS) Network (U54)
Funding Opportunity RFA-EB-15-003 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is toencourage U54 Cooperative Agreement applications for the development of enabling informatics platforms that will be designed for data acquisition from environmental, physiological, and behavior sensors that will be developed in RFA-EB-15-002 and for data integration, processing, visualization, and secure uploading of individual platform results to a data and software coordination and integration Center that will be developed in RFA-EB-15-004. The three RFAs together (RFA-EB-15-002, RFA-EB-15-003, RFA-EB-15-004) will make up the Pediatric Research using Integrated Sensor Monitoring Systems (PRISMS) Program.The central mission of the PRISMS Program is to develop sensor-based integrated health monitoring systems to serve as research tools to measure pediatric environmental, physiological, and behavioral factors in epidemiological studies of asthma, and eventually other chronic diseases, in the pediatric population. The three arms to the PRISMS Program will work very closely together to ensure functionality of the overall systems.
Wed, 25 Mar 2015 11:14:51 EST

Pediatric Research using Integrated Sensor Monitoring Systems (PRISMS): Data and Software Coordination and Integration Center (DSCIC) (U24)
Funding Opportunity RFA-EB-15-004 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage U24 applications for the development of a data and software coordination and integration center (DSCIC) that will coordinate and integrate outputs from the Informatics Technology Platform Centers (supported under RFA-EB-15-003) of the Pediatric Research using Integrated Sensor Monitoring Systems (PRISMS) Program, which also includes an initiative to fund development of sensors for pediatric asthma populations (supported under RFA-EB-15-002). The three FOAs together (RFA-EB-15-002, RFA-EB-15-003, RFA-EB-15-004) will make up the PRISMS Program.The central mission of the PRISMS Program is to develop sensor-based integrated health monitoring systems to serve as research tools to measure pediatric environmental, physiological, and behavioral factors in epidemiological studies of asthma, and eventually other chronic diseases, in the pediatric population. The three arms to the PRISMS Program will work very closely together to ensure functionality of the overall systems.
Wed, 25 Mar 2015 11:14:29 EST

Limited Competition for Renewal Applications: Collaborating Centers of Excellence in Regulatory Science and Innovation (U01)
Funding Opportunity RFA-FD-15-009 from the NIH Guide for Grants and Contracts. As part of the FDA's Advancing Regulatory Science Initiative, the Office of Chief Scientist supports innovation to improve the development of new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA regulated products. The purpose of this funding opportunity is to provide support for two Collaborating Centers of Excellence in Regulatory Science and Innovation (CERSI) at the University of Maryland, and Georgetown University.The CERSIs will continue to foster an innovative and thematically coherent approach to advance the field of regulatory science (including laboratory, population, behavioral, and manufacturing sciences) and FDA's Advancing Regulatory Science Initiative toward more effective and efficient product development and evaluation.
Thu, 26 Mar 2015 03:23:30 EST

Educating Groups Influencing Generic Drug Use (U01)
Funding Opportunity RFA-FD-15-013 from the NIH Guide for Grants and Contracts. The project purpose is to identify the key groups influencing use of generic drugs, to determine the informational needs of these groups regarding generic drugs, and to test and revise draft messages designed to address those needs. An important component of this project is capturing the extent to which the findings vary by drug class.
Wed, 25 Mar 2015 11:41:49 EST

Genome Sequencing Program Coordinating Center (U24)
Funding Opportunity RFA-HG-15-019 from the NIH Guide for Grants and Contracts. The National Human Genome Research Institute (NHGRI) will fund a new Genome Sequencing Program (GSP) that will include Centers for Common Disease Genomics (CCDG; RFA-HG-015-001), and Centers for Mendelian Genomics (CMG; RFA-HG-015-002) and a planned analysis component.
Wed, 25 Mar 2015 12:23:00 EST

Methodologies to Enhance Understanding of HIV Associated Social Determinants (R01)
Funding Opportunity RFA-MH-16-200 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that propose to understand social determinants of health as they relate to HIV infection and disease outcomes.
Tue, 24 Mar 2015 12:30:28 EST

Methodologies to Enhance Understanding of HIV Associated Social Determinants (R21)
Funding Opportunity RFA-MH-16-205 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that propose to understand social determinants of health as they relate to HIV infection and disease outcomes.
Tue, 24 Mar 2015 12:30:41 EST

Psychiatric Gene Networks: Solving the Molecular Puzzle of Psychiatric Disorders (R01)
Funding Opportunity RFA-MH-16-300 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) and the companion FOA is to solicit applications for computational and functional analysis of gene networks and complex pathways that confer susceptibility to severe mental illnesses. These studies should leverage existing diverse multi-scale datasets and apply a combination of cutting-edge bioinformatics, computational predictive modeling, and systems biology approaches to identify and begin to evaluate novel genetic factors and molecular networks underlying functional pathways relevant to psychiatric disorders to verify their relationship or causality with disease/disease risk.The computational model predictions should be further replicated through independent datasets and confirmed using biological measures from existing and/or new experimental data.
Wed, 25 Mar 2015 02:24:26 EST

Psychiatric Gene Networks: Solving the Molecular Puzzle of Psychiatric Disorders (Collaborative R01)
Funding Opportunity RFA-MH-16-310 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) and the companion FOA is to solicit applications for computational and functional analysis of gene networks and complex pathways that confer susceptibility to severe mental illnesses. These studies should leverage existing diverse multi-scale datasets and apply a combination of cutting-edge bioinformatics, computational predictive modeling, and systems biology approaches to identify and begin to evaluate novel genetic factors and molecular networks underlying functional pathways relevant to psychiatric disorders to verify their relationship or causality with disease/disease risk.The computational model predictions should be further replicated through independent datasets and confirmed using biological measures from existing and/or new experimental data.
Wed, 25 Mar 2015 02:24:11 EST

Alcohol Impairment of Immune Function, Host Defense and Tissue Homeostasis (R01)
Funding Opportunity PA-15-159 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications from researchers with broad expertise to study the consequences of alcohol consumption on immune function with a goal toward improving the outcome of patients who abuse alcohol.
Thu, 26 Mar 2015 03:14:54 EST

Exploratory/Developmental Clinical Research Grants in Obesity (R21)
Funding Opportunity PA-15-163 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages research grant applications from institutions/organizations that propose to conduct exploratory/developmental clinical studies that will accelerate the development of effective interventions for prevention or treatment of overweight or obesity in adults and/or children. Exploratory epidemiological research with a goal of informing translational/clinical research will also be supported within this program.
Fri, 27 Mar 2015 02:08:51 EST

Enhancing Developmental Biology Research at Academic Research Enhancement Award Eligible Institutions (R15)
Funding Opportunity PAR-15-149 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages grant applications to strengthen the developmental biology research environment at educational institutions that provide baccalaureate or advanced degrees, but that have not been major recipients of NIH support. In addition, this FOA attempts to foster the development of novel or underutilized experimental model systems, and to motivate students through exposure to and participation in research projects designed to study fundamental processes underlying normal development.
Mon, 23 Mar 2015 12:52:20 EST

Cancer Research Education Grants Program - Curriculum or Methods Development (R25)
Funding Opportunity PAR-15-150 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.The over-arching goal of this NCI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Curriculum or Methods Development. Applications are encouraged that propose innovative, state-of-the-art programs that address the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients, in accordance with the overall mission of the NCI.
Tue, 24 Mar 2015 09:54:51 EST

Cancer Research Education Grants Program - Courses for Skills Development (R25)
Funding Opportunity PAR-15-151 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.The over-arching goal of this NCI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development. Applications are encouraged that propose innovative, state-of-the-art programs that address the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients, in accordance with the overall mission of the NCI.
Tue, 24 Mar 2015 09:54:32 EST

Cancer Research Education Grants Program - Research Experiences (R25)
Funding Opportunity PAR-15-152 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.The over-arching goal of this NCI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs.To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Research Experiences. Applications are encouraged that propose innovative, state-of-the-art programs that address the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients, in accordance with the overall mission of the NCI.
Tue, 24 Mar 2015 09:54:21 EST

Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use Disorder and Alcohol-related Disorders (UT2)
Funding Opportunity PAR-15-153 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) directed to Small Business Technology Transfer (STTR) applicants is dedicated to the development of therapeutic agents for disorders that fall under the mission of NIAAA.An identified candidate, having sufficient bioactivity, stability, manufacturability, bioavailability, in vivo efficacy and/or target engagement, and other favorable properties that are consistent with the Small Business Technology Transfer (STTR) clinical application, is required prior to application. The FOA supports Investigational New Drug (IND)-enabling studies for the therapeutic candidate. At the end of the funding period, a successful project should have, at a minimum, an IND application submitted to the U.S. Food and Drug Administration (FDA). The program supports early-phase clinical trials, although these are not required.
Wed, 25 Mar 2015 12:48:09 EST

Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use Disorder and Alcohol-related Disorders (U44)
Funding Opportunity PAR-15-154 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that propose the development of therapeutic agents for disorders that fall under the mission of NIAAA.An identified candidate, having sufficient bioactivity, stability, manufacturability, bioavailability, in vivo efficacy and/or target engagement, and other favorable properties that are consistent with the desired clinical application, is required prior to application. The FOA supports Investigational New Drug (IND)-enabling studies for the therapeutic candidate. At the end of the funding period, a successful project should have, at a minimum, an IND application submitted to the U.S. Food and Drug Administration (FDA). The program supports early-phase clinical trials, although these are not required.
Wed, 25 Mar 2015 12:48:37 EST

Administrative Supplements to Promote Cancer Prevention and Control Research in Low and Middle Income Countries (Admin Supp)
Funding Opportunity PAR-15-155 from the NIH Guide for Grants and Contracts. The National Cancer Institute (NCI), through its Center for Global Health (CGH), seeks to promote cancer prevention and control (CPC) research in low- and middle-income countries (LMICs) through collaborations and research partnerships between the NCI-designated cancer centers and institutions in LMICs. This administrative supplement uses the World Bank's definition of LMIC. Through this funding opportunity announcement (FOA), the NCI will provide administrative supplement awards to currently-funded P30 NCI-designated cancer center grantees to support pilot research plans that focus on cancer prevention and control. The overarching purpose of these supplements is to stimulate and strengthen CPC research programs between researchers at the NCI-designated cancer centers and institutions in LMICs. It is anticipated that outcomes of this supplement will include collaborative research grants between investigators at the NCI-designated cancer centers and LMIC institutions. The applications should address questions that represent the needs of all stakeholders including the investigators, local Ministries or departments, and community members, so that the activity has a direct, local benefit. It is expected that the findings from these collaborations could improve cancer prevention and control strategies both in the US and abroad.
Thu, 26 Mar 2015 12:23:43 EST

Limited Competition: Informatics, Coordination and Service Center for the Mutant Mouse Resource and Research Centers (U42)
Funding Opportunity PAR-15-156 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to provide continuing support for the Informatics, Coordination and Service Center (ICSC) unit of the Mutant Mouse Resource and Research Centers (MMRRC) program. The ICSC is expected to provide informatics and coordinating services to the centers of the MMRRC and biomedical researchers. These services include maintenance and further development of a public website portal and Customer Service Center; operation of the order processing system; review and processing of applications from donating investigators; facilitation of interactions with biomedical investigators, informatics services, database activities, and the archive of MMRRC documents and files; coordination of requests to donate mouse strains to the MMRRC and to order mouse strains from the MMRRC; oversight of marketing efforts; and completion of monthly and yearly metrics reports. Moreover, the ICSC will host and actively participate in the monthly teleconference, annual consortium meeting, and compose reports and summaries from these forums.
Thu, 26 Mar 2015 10:28:25 EST

Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R18)
Funding Opportunity PAR-15-157 from the NIH Guide for Grants and Contracts. The purpose of this Research Demonstration and Dissemination Projects (R18) Funding Opportunity Announcement (FOA) is to encourage research applications to test approaches to improve diabetes and obesity prevention and/or treatment in routine healthcare settings.Research applications should be designed to test practical and potentially sustainable strategies to improve processes of care and health outcomes for individuals who are overweight or obese or at risk for becoming overweight or obese and/or at risk for or have type 1 or type 2 diabetes. The goal of the research is to obtain results that will improve routine healthcare practice and inform healthcare policy for the prevention or management of these conditions.
Thu, 26 Mar 2015 01:57:15 EST

Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R34)
Funding Opportunity PAR-15-158 from the NIH Guide for Grants and Contracts. The purpose of this Planning Grant (R34) Funding Opportunity Announcement (FOA) is to encourage research applications to develop and pilot test approaches to improve diabetes and obesity prevention and/or treatment in routine healthcare settings.Research applications should be designed to pilot test practical and potentially sustainable strategies to improve processes of care and health outcomes for individuals who are overweight or obese or at risk for becoming overweight or obese and/or at risk for or have type 1 or type 2 diabetes. The goal is that, if the pilot study shows promise, the data from the R34 will be used to support a full scale trial focused on improving routine healthcare practice and informing healthcare policy for the prevention or management of diabetes and obesity.
Thu, 26 Mar 2015 01:56:56 EST

Planning Grant for Global Infectious Disease Research Training Program (D71)
Funding Opportunity PAR-15-160 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites new planning grant applications for the Global Infectious Disease (GID) Research Training Program from applicants at low- and middle-income research institutions (LMICs). The application should propose plans to develop a collaborative research training program with a U.S. institution that will strengthen the capacity of the applicant institution to conduct infectious disease (excluding HIV/AIDS and select agents) research.Planning grants should describe the planning process and detailed vision for developing a research-training program that focuses on major endemic or life-threatening emerging infectious diseases, neglected tropical diseases, infections that frequently occur as co-infections in HIV infected individuals or infections associated with non-communicable disease conditions in LMICs.
Fri, 27 Mar 2015 02:39:20 EST

Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21)
Funding Opportunity PAR-15-161 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is to support Exploratory/Developmental Research Grants (R21) that propose small scale or pilot and feasibility clinical and translational research studies, including epidemiological studies or clinical trials related to kidney disease research. Studies should address important clinical and translational questions and are potentially of high clinical and public health impact. It is anticipated that some projects supported by these grants may lead to full-scale clinical studies including diagnostic strategies, epidemiological studies, or randomized clinical trials of diagnosis, prevention, or treatment of kidney diseases.
Fri, 27 Mar 2015 12:52:30 EST

Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21)
Funding Opportunity PAR-15-162 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is to support Exploratory/Developmental Research Grants (R21) that propose small scale or pilot and feasibility clinical and translational research studies, including epidemiological studies or clinical trials related to urologic disorders research. Studies should address important clinical and translational questions that are potentially of high clinical and public health impact. It is anticipated that some projects supported by these grants may lead to full-scale clinical studies including diagnostic strategies, epidemiological studies, or randomized clinical trials of prevention, diagnosis or treatment of urologic disorders.
Fri, 27 Mar 2015 12:52:19 EST